Large gap with delayed quotes
|
Official
03/28/2026
-
01:04:00
|
Bid
03/27/2026 -
21:00:00
|
Bid Volume |
Ask
03/27/2026 -
21:00:00
|
Ask Volume |
|---|---|---|---|---|
|
23.13
-1.45
(
-5.90% )
|
23.11
|
42,700 |
23.12
|
21,600 |
Analysis date: 24.03.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 06.03.2026.
Interest
Very weak
Very weak
One star since 20.03.2026.
Earnings Rev Trend
-0.10
-0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 27.02.2026 at a price of 26.40.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded below its moving average since 20.03.2026.
4wk Rel Perf
-0.77%
-0.77%
The four-week dividend-adjusted performance versus SP500 is .
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 17.03.2026.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 1.93%.
Mkt Cap in $bn
12.38
12.38
With a market capitalization >$8bn, ELANCO ANIMAL HEALTH is considered a large-cap stock.
G/PE Ratio
0.80
0.80
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
19.05
19.05
The estimated PE is for the year 2028.
LT Growth
15.31%
15.31%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
13
13
Over the last seven weeks, an average of 13 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
137
137
For 1% of index variation, the stock varies on average by 1.37%.
Correlation
0.51
0.51
50.94% of stock movements are explained by index variations.
Value at Risk
5.98
5.98
The value at risk is estimated at USD 5.98. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
08.01.2019
08.01.2019